Search

everythinglearnresearchcommunity

for

Search:↓

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

MC4R gene variants not linked to female hair loss.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Finasteride improves hair loss in women with hyperandrogenism.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

New compounds may soon be tested to treat excessive hair growth in women.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.